Arcutis Biotherapeutics ( (ARQT)) has provided an announcement. On April 10, 2025, Arcutis Biotherapeutics announced the appointment of Latha Vairavan as the new Chief Financial Officer ...

WESTLAKE VILLAGE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations ...

Arcutis Biotherapeutics (ARQT) announced that David Topper, Arcutis’ CFO is retiring from the company and Latha Vairavan, currently vice president and controller, will assume the role of CFO and ...

(RTTNews) - Calidi Biotherapeutics (CLDI) announced the appointment of Guy Travis Clifton as Chief Medical Officer, Consultant and Advisor. Clifton is a practicing surgical oncologist with over 17 ...

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...

Dr. Banerjee’s appointment culminates Artiva’s efforts to build a seasoned development team with strong expertise in autoimmune diseases and cell therapy SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- ...

The European Commission (EC) has granted marketing authorization to Rinvoq (upadacitinib; 15mg, once daily), from US pharma major AbbVie (NYSE: ABBV), for the treatment of giant cell arteritis (GCA) ...

SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell ...

SAN DIEGO - Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), a clinical-stage biotechnology company with a market capitalization of approximately $81 million, announced today the appointment of Dr ...

The Merida drugs are biotherapeutics that the startup describes as “antibody-like” in the way they move through the body. For example, these drugs could provide longer-lasting effects that ...

The latest health news includes a substantial increase in Medicare Advantage payment rates, a probe into Kellogg's health claims, and Duality Biotherapeutics' ambitious Hong Kong IPO. The news also ...